Safety Study of IL-21/Ipilimumab Combination in the Treatment of Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Ipilimumab
Related studies linked through entity extraction aliases.
A Phase II Study to Evaluate Safety and Efficacy of Combined Treatment With Ipilimumab and Intratumoral Interleukin-2
- Status
- COMPLETED
- Phase
- PHASE2
Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Stage III-IV or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy Trial of Ipilimumab Versus Pemetrexed in Non-Squamous Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012)
- Status
- COMPLETED
- Phase
- PHASE1
Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone
- Status
- COMPLETED
- Phase
- PHASE3
Pilot Ipilimumab in Stage IV Melanoma Receiving Palliative Radiation Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer
- Status
- COMPLETED
- Phase
- PHASE1
IPI-Biotherapy for Patients Previously Treated With Cytotoxic Drugs With Metastatic Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
Ipilimumab + Androgen Depravation Therapy in Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
THE IPI - Trial in Advanced Melanoma: Melanoma Patients With Advanced Disease
- Status
- COMPLETED
- Phase
- PHASE2
The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin
- Status
- COMPLETED
- Phase
- PHASE3
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Safety and Efficacy Study of BMS-908662 in Combination With Ipilimumab in Subjects With Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Ipilimumab in Patients With Advanced Melanoma and Spontaneous Preexisting Immune Response to NY-ESO-1
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Ipilimumab in Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2